HC Wainwright Increases Co-Diagnostics (NASDAQ:CODX) Price T

Co-Diagnostics (NASDAQ:CODX – Free Report) had its price target upped by HC Wainwright from $2.00 to $3.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. HC Wainwright also issued estimates for Co-Diagnostics’ Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($0.90) EPS, Q1 2024 […]

Related Keywords

United States , , Koss Olinger Consulting , Tower Research Capital , Kestra Advisory Services , Diagnostics Inc , Institutional Trading Of Co , News Ratings For Co , Dimensional Fund Advisors , Free Report , Olinger Consulting , Research Capital , Street Group , Advisory Services , Fund Advisors , Get Free Report , Co Diagnostics Daily , Co Diagnostics , Nasdaq Codx , Codx , Medical , Boost Price Target , Hc Wainwright ,